Search clinical trials for: HeRO Graft implant for dialysis access

Total 24 results

Merit Medical Systems, Inc.
CryoLife, Inc.

Withdrawn

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

End Stage Renal Failure on Dialysis

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Renal Failure Chronic Requiring Hemodialysis

United States
Merit Medical Systems, Inc.

Not yet recruiting

Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis (PReSeRVE-HD)

End Stage Renal Disease | Hemodialysis Access Failure
Vascudyne, Inc.

Completed

Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

End Stage Renal Disease

Paraguay
Baxter Healthcare Corporation

Enrolling by invitation

A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

ESRD | Acute Renal Failure | CKD | AKI - Acute Kidney Injury

Poland
Kafrelsheikh University

Recruiting

Elamrousy Modified Approach for Socket Shield Technique

Dental Implant Failed | Implant Site Reaction | Tooth Extraction Status Nos

Egypt
Phraxis, Inc.

Completed

Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]

End Stage Renal Disease

United States
Healionics Corporation

Active, not recruiting

Evaluation of STARgraft-3 for Hemodialysis

End Stage Renal Disease

Paraguay
Healionics Corporation

Completed

Evaluation of STARgraft-2 for Hemodialysis Access

End Stage Renal Disease

Paraguay
Centre Henri Becquerel

Unknown

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)

Early Stage Breast Carcinoma

France
Tanta University

Not yet recruiting

Subepithelial Connective Tissue Graft Versus Amniotic Chorion Membrane for Peri-implant Mucosal Thickness Enhancement

Dental Implant

Egypt
Universidad de Valparaiso
Universidade Federal Fluminense

Recruiting

Teriparatide on Maxillary Sinus Floor Osseointegration

Bone Regeneration

Chile
Methodist Health System

Completed

Impact of Obesity on Clinical Outcomes in Patients Receiving Acyclovir for HSV Encephalitis"

HSV Encephalitis

United States
University of Dublin, Trinity College
Health Research Board, Ireland

Enrolling by invitation

Follow-up of Inflammatory Responses and Multiorgan Outcomes FoLlowing Neonatal Brain injurY (FIREFLY)

Neonatal Encephalopathy

Ireland
University Children's Hospital Basel

Recruiting

Early Pulmonary Dysfunction in Childhood Cancer Patients (SWISS-Pearl)

Pulmonary Dysfunction

Switzerland
Assaf-Harofeh Medical Center

Recruiting

Biological Markers for Post-Traumatic Stress Disorder

Post Traumatic Stress Disorder

Israel
MeLSyTech, Ltd

Recruiting

Pelvic Organs Prolapse Treatment Using Neodymium Laser

Pelvic Organ Prolapse | Female Urogenital Diseases

Russian Federation
Hospital Mutua de Terrassa

Completed

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study (MIC project)

Inflammatory Bowel Diseases | Hepatitis C Virus Infection

Spain
University of Washington
National Cancer Institute (NCI)

Completed

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Metastatic Osteosarcoma

United States
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Inflammatory Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cardiac Toxicity

United States
Mayo Clinic
National Cancer Institute (NCI)

Suspended

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditions

United States
University of Washington
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...

United States
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome/Acute Myeloid Leukemia

United States

Search clinical trials for: HeRO Graft implant for dialysis access

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations